CD226 and neoplasm: On tumor cells, several different molecular pathways are implicated in the transcriptional upregulation of DNAM-1 ligands, including DNA Damage Response (DDR) pathways, Sonic-Hedgehog signaling pathway, cytokine production and Fibroblast Growth Factor receptor stimulation [52,53,54,55,56,57].